JACC: Case Reports (Oct 2023)
Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
Abstract
Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use of the leadless systems in the United States. (Level of Difficulty: Advanced.)